Sentinel Lymph Node Biopsy Still Provides No Benefits for Patients With Melanoma
- PMID: 32310861
- DOI: 10.1097/DAD.0000000000001656
Sentinel Lymph Node Biopsy Still Provides No Benefits for Patients With Melanoma
Comment in
-
Letter Regarding Editorial by Samuel Zagarella.Am J Dermatopathol. 2021 Jul 1;43(7):539-541. doi: 10.1097/DAD.0000000000001857. Am J Dermatopathol. 2021. PMID: 33264129 No abstract available.
References
-
- Snow H. Abstract of a lecture on melanotic cancerous disease. Lancet. 1892;140:872–874.
-
- Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977;297:627–630.
-
- Medalie NS, Ackerman AB. Sentinel lymph node biopsy has nobenefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis part I. Am J Dermatopathol. 2003;25:399–441.
-
- Meier F, Will S, Ellwnager U, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Derm. 2002;147:62–70.
-
- Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351:793–796.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
